Regulatory S16 Ep40: FDA Approval Insights: Zongertinib for HER2 TKD-Mutated NSCLC: With Julia Rotow, MD; and Martin Dietrich, MD, PhD OncLive PodcastIn today's episode, we spoke with Julia Rotow, MD, and Martin Dietrich, MD, PhD.RegulatoryOncologyRead full story pharminent March 30, 2026 (Last updated: March 31, 2026) OncLive Podcast In today’s episode, we spoke with Julia Rotow, MD, and Martin Dietrich, MD, PhD. RegulatoryOncologyRead full story Post navigation Previous: Blackstone closes $6.3B fund for life sciences investingNext: AZ considers filings for long-acting Strensiq follow-up Related Stories Regulatory Third Circuit Affirms Denial of Stelara Biosimilar Injunction pharminent May 11, 2026 Regulatory Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher pharminent May 11, 2026 Regulatory BMS’ Sotyktu secures EC approval for psoriatic arthritis pharminent May 11, 2026
